
The British Business Bank has committed €25 million to EQT Life Sciences' EQT Health Economics 3 Fund, supporting high-potential life sciences companies in the UK. This investment is part of the Bank's ongoing efforts to back the UK's life sciences sector, one of the eight growth sectors of the UK Industrial Strategy. The fund will focus on commercial-stage, de-risked medtech and digital health technologies.

Contrary to popular belief, the surge of billion-dollar 'seed' rounds in AI doesn't guarantee venture-like returns. Drawing parallels with biotech's history of capital-intensive startups, new data suggests that only a tiny fraction of mega-funded first rounds deliver exceptional investor outcomes, challenging the perceived rewrite of the venture model.
Get the top AI stories in your inbox once a day, no spam.
New stories are added every couple of hours as they break, so the feed stays current throughout the day.
We pull from 100+ sources, including company blogs, research labs, and established tech publications, then fact check and summarize each story before it goes live.
Yes. Use the sidebar filters to narrow stories down by company (OpenAI, Anthropic, Google, and more), industry, or event type like funding and research.
Yes. AI Pulse is free for anyone who wants to keep up with AI news, no sign up required. The daily newsletter is optional if you want updates in your inbox.